145 related articles for article (PubMed ID: 38735178)
1. The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage.
Mu F; Wang C; Liu L; Zeng X; Wang F
Immunobiology; 2024 May; 229(3):152808. PubMed ID: 38735178
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.
Jiang Y; Zou Q; Zhang N; Chen J; Chen X; You Q; Wu H
J Clin Pharm Ther; 2022 Dec; 47(12):2320-2324. PubMed ID: 36511097
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
4. Progestogens for preventing miscarriage: a network meta-analysis.
Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
[TBL] [Abstract][Full Text] [Related]
5. Chinese herbal medicines for unexplained recurrent miscarriage.
Li L; Dou L; Leung PC; Chung TK; Wang CC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
7. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
8. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism.
Cetin O; Karaman E; Cim N; Dirik D; Sahin HG; Kara E; Esen R
Ginekol Pol; 2017; 88(5):260-265. PubMed ID: 28580572
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
Mu F; Wang M; Huang J; Wang F
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():29-35. PubMed ID: 37276726
[TBL] [Abstract][Full Text] [Related]
10. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
Haas DM; Hathaway TJ; Ramsey PS
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003511. PubMed ID: 30298541
[TBL] [Abstract][Full Text] [Related]
11. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
12. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
Haas DM; Hathaway TJ; Ramsey PS
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745982
[TBL] [Abstract][Full Text] [Related]
13. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials.
Wang G; Zhang R; Li C; Chen A
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7601-7608. PubMed ID: 34311655
[TBL] [Abstract][Full Text] [Related]
15. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
16. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
[TBL] [Abstract][Full Text] [Related]
17. Aetiology of recurrent miscarriage and the role of adjuvant treatment in its management: a retrospective cohort review.
Dobson SJA; Jayaprakasan KM
J Obstet Gynaecol; 2018 Oct; 38(7):967-974. PubMed ID: 29557233
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
Yan X; Wang D; Yan P; Li H
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.
Chen H; Fu J; Huang W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008883. PubMed ID: 27455388
[TBL] [Abstract][Full Text] [Related]
20. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
